Long-Term Safety and Effectiveness of Lurasidone in Adolescents and Young Adults With Schizophrenia: Pooled Post-hoc Analyses of Two 12-month Extension Studies

被引：0
|
作者：
Calisti, Fabrizio [1 ]
Tocco, Michael [2 ,3 ]
Mao, Yongcai [2 ,3 ]
Pikalov, Andrei [2 ,3 ]
Goldman, Robert [2 ,3 ]
机构：
[1] Angelini Pharma SpA, Angelini RR&D Regulatory Res Dev, Viale Amelia 70, I-00181 Rome, Italy
[2] Sunov Pharmaceut Inc, Teaneck, NJ USA
[3] Sunov Pharmaceut Inc, Marlborough, MA USA
来源：
CNS SPECTRUMS | 2023年 / 28卷 / 02期
关键词：
D O I：
10.1017/S1092852923001876
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：248 / 249
页数：2
相关论文
共 50 条
  • [21] Global Improvements and Psychiatric Stability in Adults with Tardive Dyskinesia: Post Hoc Analyses of Two Long-Term Valbenazine Studies
    Cutler, Andrew
    Jain, Rakesh
    Bloom, Alon
    Siegert, Scott
    Lundt, Leslie
    NEUROLOGY, 2023, 100 (17)
  • [22] Safety of switching to brexpiprazole in Japanese patients with schizophrenia: A post-hoc analysis of a long-term open-label study
    Ishigooka, Jun
    Inada, Ken
    Niidome, Kazunari
    Aoki, Kazuo
    Kojima, Yoshitsugu
    Iwashita, Shuichi
    Yamada, Sakiko
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2021, 36 (04)
  • [23] Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: Pooled analysis of double-blind, placebo-controlled 6-week studies
    Calisti, F.
    Costamagna, I.
    Hsu, J.
    Tocco, M.
    Pikalov, A.
    Goldman, R.
    EUROPEAN PSYCHIATRY, 2021, 64 : S166 - S166
  • [24] Efficacy and safety of lurasidone in adolescents and young adults with schizophrenia: pooled analysis of double-blind, placebo-controlled 6-week studies
    Costamagna, I.
    Calisti, F.
    Hsu, J.
    Tocco, M.
    Pikalov, A.
    Goldman, R.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S473 - S474
  • [25] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [26] Lurasidone in the treatment of sleep disturbance associated with bipolar depression: post-hoc analysis of a placebo-controlled trial followed by a long-term extension study
    Tsai, J.
    Thase, M.
    Siu, C.
    Pikalov, A.
    Loebel, A.
    BIPOLAR DISORDERS, 2016, 18 : 121 - 122
  • [27] Long-term functional improving effects of cariprazine: post-hoc analyses of acute and predominant negative symptom schizophrenia patient data
    Laszlovszky, I.
    Acsai, K.
    Barabassy, A.
    Sebe, B.
    Szatmari, B.
    Vass, G.
    Earley, W.
    Nemeth, G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S326 - S327
  • [28] LONG-TERM EFFICACY OF LURASIDONE IN ANTIPSYCHOTIC-NAIVE VERSUS ANTIPSYCHOTIC-EXPOSED ADOLESCENTS WITH SCHIZOPHRENIA: POST-HOC ANALYSIS OF A 2-YEAR, OPEN-LABEL STUDY
    Correll, Christoph U.
    Goldman, Robert S.
    Tocco, Michael
    Pikalov, Andrei A.
    Hsu, Jay
    Loebel, Antony
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2019, 58 (10): : S236 - S236
  • [29] Long-term efficacy and safety of once-monthly Risperidone ISM® in the treatment of schizophrenia: Results from a 12-month open-label extension study
    Filts, Yuriy
    Litman, Robert E.
    Martinez, Javier
    Anta, Lourdes
    Naber, Dieter
    Correll, Christoph U.
    SCHIZOPHRENIA RESEARCH, 2022, 239 : 83 - 91
  • [30] Assessment of the long-term efficacy and safety of adjunctive perampanel: pooled analyses of four open-label extension studies
    Rektor, Ivan
    Krauss, Gregory L.
    Inoue, Yushi
    Kaneko, Sunao
    Williams, Betsy
    Patten, Anna
    Bibbiani, Francesco
    Laurenza, Antonio
    Wechsler, Robert T.
    NEUROLOGY, 2017, 88
12345